Mauritius vs Sur: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Mauritius
100.0%
in 2014
Sur
61.0%
in 2014
Mauritius rank
1st
Sur rank
2nd
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Mauritius
- Sur
How they compare
Mauritius currently reports 100.0% against 61.0% in Sur, a difference of 39.0%.
That makes Mauritius's figure about 1.6 times Sur's.
Across all 9 years both countries report, Mauritius has been ahead every year.
Mauritius ranks 1st and Sur ranks 2nd of 104 countries.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritius | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.2% | 19.0% | 60.2% | Mauritius |
| 2010s | 100.0% | 23.6% | 76.4% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Mauritius or Sur?
- Mauritius, at 100.0% against 61.0% in Sur as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Mauritius and Sur?
- 39.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Sur?
- 9 years are reported by both, from 2003 to 2014.
- How do Mauritius and Sur rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Mauritius ranks 1st and Sur ranks 2nd of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.